Off-Label Enforcement, Not Promotion, May See First Changes After Free Speech Ruling

In a watershed decision, a federal appeals court declares that manufacturers cannot be prosecuted under the Federal Food, Drug & Cosmetic Act’s misbranding provisions solely for speech promoting off-label use. Industry attorneys predict the decision, if it stands, will change the government’s approach to pursuing such cases.

More from Archive

More from Medtech Insight